Guide
Weight-loss medication vs lifestyle programs: what the research says
It usually isn't one or the other. FDA-approved weight-loss medicines are meant to be used alongside a reduced-calorie diet and more physical activity. Medication tends to produce larger losses, but the weight often comes back after stopping. Lifestyle change produces smaller losses that still bring real health benefits.
Side by side
| Lifestyle program | Medication plus lifestyle | |
|---|---|---|
| Typical goal or result in major studies | 5–7% of body weight (CDC Diabetes Prevention Program goal) | 12–18% more than placebo over 68–72 weeks (FDA approval data) |
| Health benefits | About 5% weight loss can improve blood pressure, cholesterol and blood sugar | Similar improvements while on treatment |
| Prescription needed | No | Yes, from a licensed provider |
| Main downsides | Takes time and steady effort | Side effects (mostly stomach-related), cost, ongoing treatment |
| After stopping | Habits can carry on | Much of the weight may return (see below) |
What happens when people stop medication
In a follow-up of one major semaglutide study, people who stopped treatment after 68 weeks regained about two-thirds of the weight they'd lost within a year. They still weighed about 5.6% less than when they started, and most health improvements moved back toward where they began. The researchers concluded that ongoing treatment may be needed to keep the benefits.
Lifestyle change on its own
- The CDC recommends a gradual pace of about 1 to 2 pounds a week, which people are more likely to keep off.
- In the study behind the CDC's National Diabetes Prevention Program, a lifestyle program aiming for 5–7% weight loss cut the risk of type 2 diabetes by 58% in adults at high risk.
Which might suit you
That depends on your BMI, your health and what you've tried before, and it's a decision to make with a licensed provider. Questions worth asking:
- Am I in the range where medication is approved? Check your BMI →
- What happens if I stop the medicine?
- What support is there for diet and activity alongside it?
Read more: How GLP-1 weight-loss medications work · How online weight-loss programs work
Sources
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension (Wilding et al., Diabetes, Obesity and Metabolism, 2022)
- FDA approves new drug treatment for chronic weight management, first since 2014 (FDA release, June 2021, via BioSpace)
- FDA approves new medication for chronic weight management — U.S. Food and Drug Administration
- Steps for losing weight — Centers for Disease Control and Prevention
- What is the National DPP? — Centers for Disease Control and Prevention